Discovery of novel mGluR5 negative allosteric modulators from structurally distinct chemotypes with pyrazolopyrazine and morpholinopyrimidone cores

被引：0
|
作者：
Claffey, Michelle M. [1 ]
机构：
[1] Pfizer Inc, Dept Neurosci Med Chem, Groton, CT 06378 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2014年 / 247卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
14-WCC
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] Development of novel chemotypes for negative allosteric modulation of mGluR5
    Felts, Andrew S.
    Lindsley, Craig W.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [2] Recent progress in the discovery and development of negative allosteric modulators of mGluR5
    Lindsley, Craig W.
    Emmitte, Kyle A.
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (04) : 446 - 457
  • [3] Rational Design of Negative Allosteric Modulators of mGluR5
    Hardy, L. W.
    Burdi, D. F.
    Hunt, R.
    Detheux, M.
    Orsini, M.
    Quinton, M. S.
    Saraswat, L.
    Lew, R.
    Spear, K.
    CURRENT NEUROPHARMACOLOGY, 2011, 9 : 28 - 28
  • [4] Challenges in the development of mGluR5 positive allosteric modulators: The discovery of CPPHA
    Zhao, Zhijian
    Wisnoski, David D.
    O'Brien, Julie A.
    Lemaire, Wei
    Williams, David L., Jr.
    Jacobson, Marlene A.
    Wittman, Marion
    Ha, Sookhee N.
    Schaffhauser, Herve
    Sur, Cyrille
    Pettibone, Doug J.
    Duggan, Mark E.
    Conn, P. Jeffrey
    Hartman, George D.
    Lindsley, Craig W.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) : 1386 - 1391
  • [5] Structure-Activity Relationships for Negative Allosteric mGluR5 Modulators
    Kaae, Birgitte H.
    Harpsoe, Kasper
    Kvist, Trine
    Mathiesen, Jesper M.
    Molck, Christina
    Gloriam, David
    Jimenez, Hermogenes N.
    Uberti, Michelle A.
    Nielsen, Soren M.
    Nielsen, Birgitte
    Brauner-Osborne, Hans
    Sauerberg, Per
    Clausen, Rasmus P.
    Madsen, Ulf
    CHEMMEDCHEM, 2012, 7 (03) : 440 - 451
  • [6] Discovery of positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5)
    Williams, DL
    Lindsley, CW
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (09) : 825 - 846
  • [7] Rapid Enabling of Negishi Couplings for a Pair of mGluR5 Negative Allosteric Modulators
    Gontcharov, Alexander
    Dunetz, Joshua R.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2014, 18 (09) : 1145 - 1152
  • [8] Pre-clinical development and safety findings of two novel mGluR5 negative allosteric modulators
    Tuttle, Jamison B.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [9] Allosteric mGluR5 antagonists: From discovery to clinical development
    Gasparini, Fabrizio
    Bilbe, Graeme
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [10] Discovery and structure-activity relationship of 1,3-cyclohexyl amide derivatives as novel mGluR5 negative allosteric modulators
    Zhou, Hao
    Topiol, Sidney W.
    Grenon, Michel
    Jimenez, Hermogenes N.
    Uberti, Michelle A.
    Smith, Daniel G.
    Brodbeck, Robbin M.
    Chandrasena, Gamini
    Pedersen, Henrik
    Madsen, Jens Christian
    Doller, Dario
    Li, Guiying
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (05) : 1398 - 1406
12345